An Act relative to furthering the success of opiate intervention programs
Generates a plain-language summary of the bill text and history.
| Date | Branch | Action |
|---|---|---|
| 3/19/2026 | House | Accompanied a study order, see H5254↗ (under House Rule 27) |
| — | House | Reported by committee to Clerk’s Office for processing, will accompany a study order |
| 6/20/2025 | Joint | Hearing scheduled for 06/26/2025 from 01:00 PM-05:00 PM in A-2 |
| 2/27/2025 | Senate | Senate concurred |
| 2/27/2025 | House | Referred to the committee on Public Safety and Homeland Security |
No additional cosponsors.
| Committee | Recommendation | Vote |
|---|---|---|
| J22 | Accompanied | — |
of Chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting at the end thereof the following:- (f) State and municipal law enforcement personnel and emergency medical personnel to include, but not limited to, emergency medical technicians (EMTs), paramedics, and fire department personnel may provide and transfer an opioid antagonist to an individual or to his or her responsible family member, friend, or other person, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to the individual, in the good-faith judgment based on their experience, training, knowledge, observations, and information provided by the individual at substantial risk of experiencing an opioid-related overdose event from the individual’s family, friend, or others with knowledge of the individual’s prior opioid use.
Section 34A of Chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting at the end thereof the following:- (f) State and municipal law enforcement personnel and emergency medical personnel to include, but not limited to, emergency medical technicians (EMTs), paramedics, and fire department personnel may provide and transfer an opioid antagonist to an individual or to his or her responsible family member, friend, or other person, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to the individual, in the good-faith judgment based on their experience, training, knowledge, observations, and information provided by the individual at substantial risk of experiencing an opioid-related overdose event from the individual’s family, friend, or others with knowledge of the individual’s prior opioid use.